OpenSourceMalaria:Compound Series: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Matthew Todd (talk | contribs) (Created Series Summary Page) |
Matthew Todd (talk | contribs) (Added new page on repurposing) |
||
(6 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{OpenSourceMalaria}} | {{OpenSourceMalaria}} | ||
[[OpenSourceMalaria:GSK_Arylpyrrole_Series |'''Series 1: GSK Arylpyrroles''']] | A summary of progress in the OSM project may be found in the [[OpenSourceMalaria:Story_so_far|Story so Far]]. The pages below include the technical detail of the individual series examined and are written for scientific contributors. | ||
[[OpenSourceMalaria:GSK_Triazolourea_Singleton |'''Series 2: GSK Triazoloureas''']] | |||
[[OpenSourceMalaria:GSK_Amino-thienopyrimidine_Series |'''Series 3: GSK Thienopyrimidines''']] | [[OpenSourceMalaria:GSK_Arylpyrrole_Series |'''Series 1: GSK Arylpyrroles''']] (being written up) | ||
[[OpenSourceMalaria:GSK_Triazolourea_Singleton |'''Series 2: GSK Triazoloureas''']] (parked) | |||
[[OpenSourceMalaria:GSK_Amino-thienopyrimidine_Series |'''Series 3: GSK Thienopyrimidines''']] (final compounds being made) | |||
[[OpenSourceMalaria:Triazolopyrazine_(TP)_Series |'''Series 4: Triazolopyrazines (TPs)''']] (currently most active) | |||
[[OpenSourceMalaria:Obtaining Compounds for OSM |'''Obtaining Compounds for OSM''']] | |||
[[OpenSourceMalaria:Repurposing |'''Repurposing''']] | |||
[[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | [[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] |
Revision as of 18:03, 30 June 2014
A summary of progress in the OSM project may be found in the Story so Far. The pages below include the technical detail of the individual series examined and are written for scientific contributors.
Series 1: GSK Arylpyrroles (being written up)
Series 2: GSK Triazoloureas (parked)
Series 3: GSK Thienopyrimidines (final compounds being made)
Series 4: Triazolopyrazines (TPs) (currently most active)